COLLEGIUM PHARMACEUTICAL, INC
COLL$1.03B
Small CapNASDAQPharmaceutical Preparations🇺🇸North AmericaSTOUGHTON357 employees
Drugs in Pipeline
1
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
COLL News
Catalyst Timeline
1 upcoming, 1 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Oxycodone DETERx | Phase 3 | Chronic Low Back Pain | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply